Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors

Download

index.pdf

Date

2023-03-01

Author

Zapata, Luis
Caravagna, Giulio
Williams, Marc J.
Lakatos, Eszter
Abduljabbar, Khalid
Werner, Benjamin
Chowell, Diego
James, Chela
Gourmet, Lucie
Milite, Salvatore
Acar, Ahmet
Riaz, Nadeem
Chan, Timothy A.
Graham, Trevor A.
Sottoriva, Andrea

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

139
views

78
downloads

In cancer, evolutionary forces select for clones that evade the immune system. Here we analyzed >10,000 primary tumors and 356 immune-checkpoint-treated metastases using immune dN/dS, the ratio of nonsynonymous to synonymous mutations in the immunopeptidome, to measure immune selection in cohorts and individuals. We classified tumors as immune edited when antigenic mutations were removed by negative selection and immune escaped when antigenicity was covered up by aberrant immune modulation. Only in immune-edited tumors was immune predation linked to CD8 T cell infiltration. Immune-escaped metastases experienced the best response to immunotherapy, whereas immune-edited patients did not benefit, suggesting a preexisting resistance mechanism. Similarly, in a longitudinal cohort, nivolumab treatment removes neoantigens exclusively in the immunopeptidome of nonimmune-edited patients, the group with the best overall survival response. Our work uses dN/dS to differentiate between immune-edited and immune-escaped tumors, measuring potential antigenicity and ultimately helping predict response to treatment.

URI

https://hdl.handle.net/11511/102756

Journal

Nature Genetics

DOI

https://doi.org/10.1038/s41588-023-01313-1

Collections

Department of Biology, Article

Suggestions

OpenMETU
Core

Driver Subnetwork Identification by Community Detection and Network Dismantling Methods Bas, Fatma Ulkem; Dikli, Sertan Ali; Tunçbağ, Nurcan (Orta Doğu Teknik Üniversitesi Enformatik Enstitüsü; 2022-10) During the tumor evolution, cancer driver mutations accumulate on some specific genes (oncogenes, tumor suppressors) which promote cell proliferation. Driver mutations generally show themselves as a deleterious mutation in the tumor-suppressor genes, such as p53. Similarly, proto-oncogenes can be mutated and turn into oncogenes, which, as the name implies, means the cancer-inducing genes being expressed higher than their trending levels. These biomarkers altogether are called cancer driver genes in the exte...
Cytotoxic T Lymphocyte Activation Signals Modulate Cytoskeletal Dynamics and Mechanical Force Generation Pathni, Aashli; Özçelikkale, Altuğ; Rey-Suarez, Ivan; Li, Lei; Davis, Scott; Rogers, Nate; Xiao, Zhengguo; Upadhyaya, Arpita (2022-03-01) Cytotoxic T lymphocytes (CTLs) play an integral role in the adaptive immune response by killing infected cells. Antigen presenting cells (APCs), such as dendritic cells, present pathogenic peptides to the T cell receptor on the CTL surface and co-stimulatory signals required for complete activation. Activated CTLs secrete lytic granules containing enzymes that trigger target cell death at the CTL-target contact, also known as the immune synapse (IS). The actin and microtubule cytoskeletons are instrumental ...
CpG oligodeoxynucleotides protect normal and SIV-infected macaques from Leishmania infection. Verthelyi, D; Gürsel, Mayda; Kenney, RT; Lifson, JD; Liu, S; Mican, J; Klinman, DM (The American Association of Immunologists, 2003-05-01) Oligodeoxynucleotides containing CpG motifs (CpG ODNs) mimic microbial DNA and activate effectors of the innate immune response, which limits the spread of pathogens and promotes an adaptive immune response. CpG ODNs have been shown to protect mice from infection with intracellular pathogens. Unfortunately, CpG motifs that optimally stimulate humans are only weakly active in mice, mandating the use of nonhuman primates to monitor the activity and safety of "human" CpG ODNs in vivo. This study demonstrates t...
Differential immune activation following encapsulation of immunostimulatory CpG oligodeoxynucleotide in nanoliposomes. Erikçi, E; Gürsel, Mayda; Gürsel, I (2011-02-01) The immunogenicity of a vaccine formulation is closely related to the effective internalization by the innate immune cells that provide prolonged and simultaneous delivery of antigen and adjuvant to relevant antigen presenting cells. Endosome associated TLR9 recognizes microbial unmethylated CpG DNA. Clinical applications of TLR9 ligands are significantly hampered due to their pre-mature in vivo digestion and rapid clearance. Liposome encapsulation is a powerful tool to increase in vivo stability as well as...
Pan-cancer clinical impact of latent drivers from double mutations Yavuz, Bengi Ruken; Tsai, Chung-Jung; Nussinov, Ruth; Tuncbag, Nurcan (2023-12-01) Here, we discover potential ‘latent driver’ mutations in cancer genomes. Latent drivers have low frequencies and minor observable translational potential. As such, to date they have escaped identification. Their discovery is important, since when paired in cis, latent driver mutations can drive cancer. Our comprehensive statistical analysis of the pan-cancer mutation profiles of ~60,000 tumor sequences from the TCGA and AACR-GENIE cohorts identifies significantly co-occurring potential latent drivers. We ob...

Citation Formats

L. Zapata et al., “Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors,” Nature Genetics, vol. 55, no. 3, pp. 451–460, 2023, Accessed: 00, 2023. [Online]. Available: https://hdl.handle.net/11511/102756.